Neurim Pharmaceuticals can seek limited additional damages in a patent infringement case relating to its insomnia drug Circadin, after a judge granted a mid-trial bid to amend its pleadings against Generic Partners and Apotex.
Judge wants to avoid ‘behemoth’ trial in $500M combustible cladding class action
Reckitt’s ‘weak’ case dooms bid to kill Raid Max ads
‘Risky, illiquid and speculative’: Class action launched over Mayfair’s failed IPO Wealth Fund
Crown Resorts hit with class action over money laundering compliance
Law firm’s ‘overly combative manner’ prompts independent counsel appointment in bushfire class actions
A judge will appoint an independent barrister to determine the allocation of settlement proceeds between insured group members and their insurers from two St Patrick’s Day bushfire class actions, finding that the ‘overly combative’ conduct of law firm Maddens warranted the appointment despite the extra costs involved.